コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 Coats define the composition of carriers budding from or
2 Coats plus (CP) can be caused by mutations in the CTC1 c
3 Coats plus is a highly pleiotropic disorder particularly
4 Coats' disease is characterized by abnormal retinal vasc
5 patients who underwent treatment for stage 2 Coats' disease in a tertiary center in the United Kingdo
6 e intraoperative FA in children with stage 2 Coats' disease led to good anatomic outcome, with preser
7 (n = 15, 22%), pars planitis (n = 14, 21%), Coats disease (n = 11, 16%), previous retinal detachment
8 n 1 year were most likely to have PFV (49%), Coats' disease (20%), or vitreous hemorrhage (7%); those
9 an important pathophysiological link between Coats plus and the clinically related telomere disorders
10 ve vitreoretinopathy (FEVR), Norrie disease, Coats' disease, bilateral persistent fetal vasculature,
11 older than 5 years were most likely to have Coats' disease (57%), toxocariasis (8%), or FEVR (6%).
12 2 to 5 years of age were most likely to have Coats' disease (61%), toxocariasis (8%), or PFV (7%); an
13 he most common pseudoretinoblastomas include Coats' disease, PFV, and vitreous hemorrhage, but the sp
14 conditions, and the 10 most common included Coats' disease (n = 244; 40%), persistent fetal vasculat
17 is CTC1 mutant and the phenotypic overlap of Coats plus with the telomeric maintenance disorders comp
19 r the formation of retinal telangiectasia or Coats-like vasculopathy in patients with CRB1 mutations
24 hortened telomeres in three individuals with Coats plus and an increase in spontaneous gammaH2AX-posi
25 inas of nine enucleated eyes from males with Coats' disease demonstrated in one a somatic mutation in
27 ences in visual acuities among patients with Coats' disease who sought treatment at a tertiary care u
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。